Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-07-29

Clinical Trial Update: Comparative Clinical Study Between Colistin-Tigecycline Combined Therapy Versus Colistin-Meropenem Combined Therapy in Treatment of Blood Stream Infections With Multidrug-Resistant Klebsiella Pneumoniae [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing colistin-tigecycline versus colistin-meropenem in treating bloodstream infections caused by multidrug-resistant Klebsiella pn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Colistin and Meropenem
  • Colistin and Tigecycline

Snippet

Sponsor: Al-Azhar University | Conditions: Treatment of Blood Stream Infections Due to Multidrug-Resistant Klebsiella Pneumoniae | Phase 4 | Status: UNKNOWN